Skip to main content

Table 1 Correlation of SOX30 expression with clinicopathologic features in ADC patients (n = 275)

From: SOX30 specially prevents Wnt-signaling to suppress metastasis and improve prognosis of lung adenocarcinoma patients

Clinical feature Total SOX30 expression P value
High (n = 94) Low (n = 181)
Age (years)
  ≤ 60 151 56 95 0.328
  > 60 121 38 83  
Clinical stage
 I 116 42 74 0.023
 II 39 14 25  
 III 56 13 43  
 IV 16 1 15  
Tumor size
 T1–2 213 76 137 0.012
 T3–4 31 4 27  
Lymph node status
 N0 128 45 83 0.160
 N1–3 95 25 70  
Metastasis
 M0 230 78 152 0.022
 M1 16 1 15  
Gender
 Male 152 52 100 0.991
 Female 123 42 81  
Histological grade
 1 28 7 21 0.486
 2 108 40 68  
 3 70 25 45  
Tumor diameter
  ≤ 4 cm 196 72 124 0.082
  > 4 cm 71 18 53  
Location
 Left 125 46 79 0.426
 Right 149 48 101  
  1. The p values were measured with Pearson chi-square tests
  2. The tumor clinical stage, tumor status, lymph node status and metastasis were classified according to the international system
  3. All statistical tests are two sided
  4. The entries in boldface indicate statistically significant